Vitamin-K-Mangel
Begutachtet von Dr Jacqueline Payne, FRCGPZuletzt aktualisiert von Dr Laurence KnottZuletzt aktualisiert 15. Feb 2019
Erfüllt die Anforderungen des Patienten Richtlinien des Patienten
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Audio-Version
Diese Seite wurde archiviert.
Es wurde kürzlich nicht überprüft und ist nicht auf dem neuesten Stand. Externe Links und Referenzen funktionieren möglicherweise nicht mehr.
Medizinische Fachkräfte
Fachartikel sind für die Nutzung durch Gesundheitsfachkräfte konzipiert. Sie werden von britischen Ärzten verfasst und basieren auf Forschungsergebnissen, britischen und europäischen Richtlinien. Möglicherweise finden Sie einen unserer Gesundheitsartikel nützlicher.
In diesem Artikel:
Vitamin K is found in green leafy vegetables and oils, such as olive, cotton seed and soya bean. Other foods rich in vitamin K are green peas and beans, watercress, asparagus, spinach, broccoli, oats and whole wheat. Vitamin K is also synthesised by colonic bacteria1.
Vitamin K is an essential lipid-soluble vitamin. It is a co-factor in the synthesis of clotting factors II, VII, IX and X2.
Vitamin K is also very important for bone health. Vitamin K deficiency is thought to cause impaired activation of bone matrix protein osteocalcin, and reduction of osteoblast function, resulting in impaired bone formation. However, the clinical significance of this has not yet been fully evaluated3.
There is growing evidence for a role of vitamin K in vascular health4.
Lesen Sie unten weiter
Epidemiologie
Deficiency can occur in persons of any age but neonates are at risk of developing vitamin K deficiency bleeding (see the separate Vitamin K Deficiency Bleeding article). This is because of a lack of vitamin K reaching the fetus across the placenta, the low level of vitamin K in breast milk and low colonic bacterial synthesis.
Vitamin K deficiency is uncommon in otherwise healthy adults.
Risikofaktoren
Excessive anticoagulation with coumarins - eg, warfarin.
Liver disease: for example, cirrhosis, malignancy, amyloidosis and Gaucher's disease decrease the synthesis of vitamin K-dependent factors.
Malabsorption: coeliac disease, tropical sprue, Crohn's disease, ulcerative colitis, ascariasis, short bowel syndrome due to multiple abdominal surgeries, bacterial overgrowth, and chronic pancreatitis.
Biliary tract disease: common duct obstruction due to stones and strictures, primary biliary cirrhosis, cholangiocarcinoma, and chronic cholestasis. Leads to a decrease in fat absorption and so a deficiency of fat-soluble vitamins.
Dietary deficiency occurs in people with malnutrition, including people with alcoholism, as well as in patients undergoing long-term parenteral nutrition without vitamin K supplements.
Drugs: colestyramine, salicylates, rifampin, isoniazid and barbiturates are some of the common drugs that are associated with vitamin K deficiency.
Diseases with endogenously produced coagulation inhibitors (eg, lupus anticoagulant and antithrombins) and paraproteinaemias such as myeloma, may cause vitamin K deficiency.
Miscellaneous causes include massive transfusion, disseminated intravascular coagulation, polycythaemia vera, nephrotic syndrome, cystic fibrosis, and leukaemia.
Präsentation
Zurück zum InhaltSiehe die separate Vitamin K Deficiency Bleeding article for presentation in infants.
The clinical manifestations in adults are evident only if hypoprothrombinaemia is present:
Bleeding is the major symptom, especially in response to minor or trivial trauma.
Any site can be involved, including mucosal and subcutaneous bleeding, such as epistaxis, petechiae, haematoma, gastrointestinal bleeding, menorrhagia, haematuria and bleeding from gums.
Lesen Sie unten weiter
Differentialdiagnose
Zurück zum InhaltVitamin K deficiency needs to be considered as a possible cause of any bleeding disorder.
The differential diagnosis therefore includes Leukämie, disseminated intravascular coagulation, dysfibrinogenaemia, immune thrombocytopenia, scurvy, thrombotic thrombocytopenic purpura und von-Willebrand-Syndrom.
Untersuchungen
Zurück zum InhaltBleeding time, prothrombin time and activated partial thromboplastin time are all elevated.
The most sensitive marker is the antibody test for high level of des-gamma-carboxy prothrombin (DCP) protein in vitamin K absence (PIVKA).
The plasma level of vitamin K can be measured.
Lesen Sie unten weiter
Behandlung
Zurück zum InhaltTherapy depends on the severity of the bleeding and the underlying cause.
In life-threatening bleeds, fresh frozen plasma (FFP) should be administered prior to vitamin K.
Vitamin K is available as phytomenadione (vitamin K) and as the synthetic water-soluble analogue menadiol sodium diphosphate.
Intravenous (IV) injections should be given slowly, as fast IV injection can cause bronchospasm and peripheral vascular collapse.
Intramuscular injections may lead to severe haematoma formation at the injection site if clotting is impaired.
Infants
Siehe die separate Vitamin K Deficiency Bleeding Artikel.
Haemorrhage in people taking warfarin
Siehe die separate Oral Anticoagulants Artikel.
Prognose
Zurück zum InhaltPatients have a very good prognosis if the vitamin K deficiency is recognised early and treated appropriately.
Morbidity correlates with severity of vitamin K deficiency, but severe bleeding can be fatal.
Prävention
Zurück zum InhaltA diet rich in vitamin K - eg, green leafy vegetables and oils (such as olive, cotton seed and soya beans), green peas and beans, watercress, asparagus, spinach, broccoli, oats and whole wheat.
Vitamin K given to neonates is very effective in preventing vitamin K deficiency bleeding.
Menadiol sodium phosphate is a water-soluble synthetic vitamin K derivative that can be given orally to prevent vitamin K deficiency in malabsorption syndromes5.
Weiterführende Lektüre und Referenzen
- Dong R, Wang N, Yang Y, et al; Review on Vitamin K Deficiency and its Biomarkers: Focus on the Novel Application of PIVKA-II in Clinical Practice. Clin Lab. 2018 Apr 1;64(4):413-424. doi: 10.7754/Clin.Lab.2017.171020.
- Schwalfenberg GK; Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health. J Nutr Metab. 2017;2017:6254836. doi: 10.1155/2017/6254836. Epub 2017 Jun 18.
- Piscaer I, Wouters EFM, Vermeer C, et al; Vitamin K deficiency: the linking pin between COPD and cardiovascular diseases? Respir Res. 2017 Nov 13;18(1):189. doi: 10.1186/s12931-017-0673-z.
- Aydin S; Can vitamin K synthesis altered by dysbiosis of microbiota be blamed in the etiopathogenesis of venous thrombosis? Biosci Microbiota Food Health. 2017;36(3):73-74. doi: 10.12938/bmfh.17-007. Epub 2017 Apr 21.
- Tie JK, Carneiro JD, Jin DY, et al; Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders. Blood. 2016 Apr 14;127(15):1847-55. doi: 10.1182/blood-2015-10-677633. Epub 2016 Jan 12.
- Akbari S, Rasouli-Ghahroudi AA; Vitamin K and Bone Metabolism: A Review of the Latest Evidence in Preclinical Studies. Biomed Res Int. 2018 Jun 27;2018:4629383. doi: 10.1155/2018/4629383. eCollection 2018.
- van Ballegooijen AJ, Beulens JW; The Role of Vitamin K Status in Cardiovascular Health: Evidence from Observational and Clinical Studies. Curr Nutr Rep. 2017;6(3):197-205. doi: 10.1007/s13668-017-0208-8. Epub 2017 Jul 10.
- Britisches Nationales Arzneimittelverzeichnis (BNF); NICE Evidenzdienste (nur in Großbritannien zugänglich)
Lesen Sie unten weiter
Artikelverlauf
Die Informationen auf dieser Seite wurden von qualifizierten Klinikern verfasst und begutachtet.
15. Feb 2019 | Neueste Version

Fragen, teilen, verbinden.
Durchsuchen Sie Diskussionen, stellen Sie Fragen und teilen Sie Erfahrungen zu Hunderten von Gesundheitsthemen.

Fühlen Sie sich unwohl?
Bewerten Sie Ihre Symptome online kostenlos